Literature DB >> 23321472

Epidemiology of recurrent tuberculosis in the United States, 1993-2010.

L Kim1, P K Moonan, R S Yelk Woodruff, J S Kammerer, M B Haddad.   

Abstract

Recurrent tuberculosis (TB) can result from reactivation of a previous TB episode or reinfection with a new Mycobacterium tuberculosis strain. A retrospective analysis of all recurrent TB cases reported in the United States during 1993-2010 was conducted. The proportion of recurrent cases remained stable during the study period (annual range 4.2-5.7%). Compared with persons without a previous diagnosis of TB, persons with recurrent TB experienced lower treatment completion within 12 months and higher mortality during the recurrent episode. Persons with recurrent TB have poorer outcomes, suggesting the need for targeted interventions to ensure treatment completion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23321472     DOI: 10.5588/ijtld.12.0640

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Factors associated with recurrent tuberculosis more than 12 months after treatment completion.

Authors:  L Kim; P K Moonan; C M Heilig; R S Yelk Woodruff; J S Kammerer; M B Haddad
Journal:  Int J Tuberc Lung Dis       Date:  2016-01       Impact factor: 2.373

2.  Exogenous Reinfection as a Cause of Late Recurrent Tuberculosis in the United States.

Authors:  Julia D Interrante; Maryam B Haddad; Lindsay Kim; Neel R Gandhi
Journal:  Ann Am Thorac Soc       Date:  2015-11

3.  Tuberculosis recurrence in a priority city in the state of São Paulo, Brazil.

Authors:  Amadeu Antonio Vieira; Danila Torres Leite; Solange Adreoni
Journal:  J Bras Pneumol       Date:  2017 Mar-Apr       Impact factor: 2.624

4.  Recurrent tuberculosis in Finland 1995-2013: a clinical and epidemiological cohort study.

Authors:  Virve Korhonen; Hanna Soini; Tuula Vasankari; Jukka Ollgren; Pieter W Smit; Petri Ruutu
Journal:  BMC Infect Dis       Date:  2017-11-16       Impact factor: 3.090

5.  Epidemiology of recurrent pulmonary tuberculosis by bacteriological features of 100 million residents in China.

Authors:  Hui Jiang; Jinfeng Yin; Xu Gao; Wangli Xu; Weimin Li; Guolong Zhang; Fangchao Liu; Yuxia Yao; Chao Cai; Jiying Xu; Lijun Zheng; Chendi Zhu; Junnan Jia
Journal:  BMC Infect Dis       Date:  2022-07-22       Impact factor: 3.667

6.  Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts.

Authors:  Vidya Mave; Jonathan E Golub; Samyra R Cox; Abhay Kadam; Sachin Atre; Akshay N Gupte; Hojoon Sohn; Nikhil Gupte; Trupti Sawant; Vishal Mhadeshwar; Ryan Thompson; Emily Kendall; Christopher Hoffmann; Nishi Suryavanshi; Deanna Kerrigan; Srikanth Tripathy; Arjunlal Kakrani; Madhusudan S Barthwal
Journal:  Trials       Date:  2022-08-05       Impact factor: 2.728

7.  The incidence of recurrence of tuberculosis and its related factors in smear-positive pulmonary tuberculosis patients in Iran: A retrospective cohort study.

Authors:  Mahmood Moosazadeh; Abbas Bahrampour; Mahshid Nasehi; Narges Khanjani
Journal:  Lung India       Date:  2015 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.